Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Trial Testing Engineered Virus as Cancer Treatment

A clinical trial is underway testing a genetically engineered virus to kill cancer cells, then stimulate the immune system to treat solid tumor cancers. . . . → Read More: Trial Testing Engineered Virus as Cancer Treatment

Alliance to Develop Rare Cancer Preclinical Models

A coalition of a patient advocacy organization, research institute, and cancer research company are implanting mice with human tumors to help study a rare form of cancer. . . . → Read More: Alliance to Develop Rare Cancer Preclinical Models

FDA Clears Algorithm-Assisted Cancer Diagnosis

The U.S. Food and Drug Administration cleared for marketing a diagnostics system aided by machine learning algorithms to help radiologists detect breast cancer. . . . → Read More: FDA Clears Algorithm-Assisted Cancer Diagnosis

Patent Awarded for Exosome Capture Process

A company making blood filtering devices was awarded a patent for a process to capture tiny particles carrying proteins that suppress immune responses. . . . → Read More: Patent Awarded for Exosome Capture Process

Nanotech Treatment Studied for Brain Tumors

Medical researchers and engineers designed and tested in mice a way to deliver gene-silencing therapies in nanoscale particles to treat glioblastoma, an aggressive form of brain cancer. . . . → Read More: Nanotech Treatment Studied for Brain Tumors

Lab-On-Chip Quickly Isolates, Captures Exosomes

Tests of a lab-on-a-chip system show the device can rapidly isolate and recover cellular carriers of biomarkers useful in detecting cancer and other diseases. . . . → Read More: Lab-On-Chip Quickly Isolates, Captures Exosomes

Feasibility, Safety Shown for Personal Tumor Vaccine

A pilot study among individuals with a form of skin cancer shows a vaccine aiming at proteins specific to a person’s tumor is safe and can generate a complex immune response attacking the tumor. . . . → Read More: Feasibility, Safety Shown for Personal Tumor Vaccine

NIH Funds Nanotech Tools for Cancer, Blood Clots

A bioengineering lab is receiving awards from National Institutes of Health to apply nanotechnology to treatments for breast cancer and diagnostics for deep vein blood clots. . . . → Read More: NIH Funds Nanotech Tools for Cancer, Blood Clots

Second Trial Approved for Cancer Pain Drug

The U.S. Food and Drug Administration approved a new clinical trial to test the efficacy and safety of an experimental drug designed to relieve stubborn chronic pain associated with cancer. . . . → Read More: Second Trial Approved for Cancer Pain Drug

Cancer Drug Produced in Small Continuous-Flow Batches

A team from drug maker Eli Lilly & Company devised techniques for producing an experimental cancer drug in small quantities but with safe, economical methods used in continuous flow manufacturing. . . . → Read More: Cancer Drug Produced in Small Continuous-Flow Batches